The impact of bariatric and metabolic surgery on cancer development
In 2024, a group of researchers explored the relationship between GLP-1 medications and hair loss by searching reports between 2022 and 2023 related to GLP-1 medications and hair loss
( A L ) Plasma concentrations of GLP-1 (active) ( A ), insulin ( B ), leptin ( C ), PYY ( D ), C-peptide 2 ( E ), GIP (total) ( F ), amylin ( G ), glucagon ( H ), PP ( I ), ghrelin ( J ), resistin ( K ), and secretin ( L ) in 22- to 28-week-old female ad libitum chow-fed WT C57BL/6J and Bbs5 / mice ( n = 5 per group) before and after semaglutide therapy
95% CI, 0.38-0.89), SU (HR, 0.63
It is often seen at low levels in chronic diseases such as Lyme disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 843